Succinivibrionaceae is dominant family in fecal microbiota of Behçet’s Syndrome patients with uveitis-Reference-Cited by-同舟云学术

Succinivibrionaceae is dominant family in fecal microbiota of Behçet’s Syndrome patients with uveitis

Published:2020-10-30 Issue:10 Volume:15 Page:e0241691
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tecer Duygu,Gogus Feride,Kalkanci Ayse^ORCID,Erdogan Merve,Hasanreisoglu Murat^ORCID,Ergin Çagri,Karakan Tarkan^ORCID,Kozan Ramazan^ORCID,Coban Seda,Diker Kadir Serdar

Funder

Turkish League Against Rheumatism

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Pathogenesis of Behçet’s disease: autoinflammatory features and beyond;A Gül;Semin Immunopathol,2015

2. Target organ associations in Turkish patients with Behçet’s disease: a cross sectional study by exploratory factor analysis;R Tunc;J Rheumatol,2002

3. The association between HLA B5 and ocular involvement in Behcet’s disease in southern Turkey;M Soylu;Acta Ophthalmol (Copenh),1992

4. Is Behçet’s disease a “class 1 opathy”? The role of HLA-B*51 in the pathogenesis of Behçet’s disease;M Giza;Clin Exper Immunol,2017

5. Update on the epidemiology, risk factors and disease outcomes of Behcet’s disease;N Akkoc;Best Pract Res Clin Rheumatol,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal microbiota transplantation for the treatment of chronic inﬂammatory skin diseases;Heliyon;2024-09

2. Characterizing the gastrointestinal microbiome diversity in endangered Malayan Siamang (Symphalangus syndactylus): Insights into group composition, age variability and sex‐related patterns;Journal of Medical Primatology;2024-08-15

3. A two sample mendelian randomization analysis investigates causal effects between gut microbiome and immune related Vasculitis;Scientific Reports;2024-08-13

4. Causal effects of the gut microbiome on immune-related vasculitis: A two-sample Mendelian randomization study;2024-01-25

5. Fecal Microbiota Transplantation for the Treatment of Chronic Inﬂammatory Skin Diseases;2024